Medistim ASA (OSL:MEDI)
Norway · Delayed Price · Currency is NOK 229.00
+3.00 (1.33%)
Aug 4, 2026, 4:25 PM CET
Medistim ASA Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 201.66 | 206.85 | 134.25 | 135.21 | 146.05 | 90.9 |
Depreciation & Amortization | -1.5 | 16.02 | 15.4 | 23.66 | 23.29 | 23.43 |
Stock-Based Compensation | - | 3.22 | 1.07 | 6.01 | - | - |
Other Adjustments | - | - | - | - | - | 23.17 |
Change in Receivables | - | -17.41 | 5.32 | 27.35 | -33.02 | -11.15 |
Changes in Inventories | - | -0.61 | -15.13 | -31.06 | -16.92 | 15.25 |
Changes in Accounts Payable | - | 8.9 | 1.95 | 0.61 | 11.27 | -0.32 |
Changes in Income Taxes Payable | -9.49 | -28.34 | -28.4 | -25.7 | -19.17 | -13.34 |
Changes in Other Operating Activities | -10.7 | -1.54 | 28.67 | -16.89 | 2 | -0.57 |
Operating Cash Flow | 179.97 | 187.08 | 143.1 | 119.2 | 113.49 | 127.37 |
Operating Cash Flow Growth | 30.17% | 30.73% | 20.06% | 5.03% | -10.90% | 71.82% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | -15.53 | -6.07 | -16.4 | -9.25 | -7.4 |
Purchases of Intangible Assets | - | -17.48 | -18.63 | -13.33 | -11.85 | -4.08 |
Other Investing Activities | -6.63 | - | - | - | - | - |
Investing Cash Flow | -6.63 | -33.01 | -24.69 | -29.73 | -21.1 | -11.49 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | - | - | - | - | -4.5 |
Net Long-Term Debt Issued (Repaid) | - | - | - | - | - | -4.5 |
Repurchase of Common Stock | 3.51 | -4.65 | - | - | - | - |
Net Common Stock Issued (Repurchased) | 3.51 | -4.65 | - | - | - | - |
Common Dividends Paid | -109.47 | -109.47 | -82.41 | -82.18 | -68.4 | -54.64 |
Other Financing Activities | -9.52 | -9.36 | -9.12 | -8.71 | -1.91 | 0.09 |
Financing Cash Flow | -115.48 | -123.48 | -91.53 | -90.89 | -70.3 | -59.05 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | 2.28 | -1.54 | 2.65 | 1.07 | 0.76 |
Net Cash Flow | 26.34 | 32.88 | 25.34 | 1.23 | 23.15 | 57.6 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 179.97 | 171.56 | 137.04 | 102.8 | 104.24 | 119.97 |
Free Cash Flow Growth | 30.17% | 25.19% | 33.30% | -1.38% | -13.11% | 79.91% |
FCF Margin | 25.00% | 24.52% | 24.36% | 19.53% | 21.19% | 28.08% |
Free Cash Flow Per Share | 9.85 | 9.39 | 7.48 | 5.62 | 5.70 | 6.57 |
Levered Free Cash Flow | 134.39 | 138.1 | 100.24 | 38.05 | 105.19 | 103.45 |
Unlevered Free Cash Flow | 128.55 | 129.9 | 97.79 | 35.15 | 101.44 | 109.71 |